CFM
DRTS icon

Catalyst Funds Management’s Alpha Tau Medical DRTS Stock Holding History

Catalyst Funds Management’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+16,500
New +$150K 0.01% 583

Other funds holding DRTS

GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Catalyst Funds Management's DRTS Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in Alpha Tau Medical (DRTS) in Q2 2026: 16,500 shares worth $208K. The stake represents 0.01% of the portfolio and ranks #583 among its holdings.

74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Catalyst Funds Management held 16,500 shares of Alpha Tau Medical worth $208K as of Q2 2026.
  • Alpha Tau Medical was a new Catalyst Funds Management position in Q2 2026.
  • Alpha Tau Medical made up 0.01% of Catalyst Funds Management's portfolio in Q2 2026, its #583 holding.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.